Aurealix

Adaptive intelligence for the nervous system.

Historically learning. Personally optimized. Scientifically validated.

Aurealix develops adaptive, AI-driven wearable systems that learn from the body, map functional responses, and deliver personalized neuromodulation.

Adaptive AI Platform

Continuously learns from multimodal data to build a historical model of functional responses.

Personalized Neuromodulation

Delivers targeted interactions through intelligent selection of stimulation parameters and locations.

First Validation: Chronic Pain

Initial clinical focus on measurable outcomes, safety and real-world impact.

Future Applications

Enabling functional neurocartography for broader bioelectronic medicine applications.

Technology

Historically learning bioelectronic systems.

Aurealix combines wearable sensing, adaptive interaction, closed-loop control and patient-specific functional response modelling. The platform supports detection, hypothesis formation, verification and adaptive interaction optimization across repeated sessions.

Validation

First clinical use case: chronic pain.

The initial validation route focuses on adaptive neuromodulation for chronic pain, using reproducible localization, multimodal physiological signals and measurable clinical outcomes as the first demonstration case.

Intellectual Property

Protected platform architecture.

Protected by an expanding intellectual property portfolio including 18 Dutch patent applications and an international PCT application.

Collaboration

Academic, clinical and industrial partners.

Aurealix welcomes discussions with universities, research institutes, clinical partners, technology companies and consortium initiatives.

Our mission

To build historically learning wearable systems that unlock the potential of personalized neuromodulation and functional neurocartography.